PIethico
Pledged to ethics
PLETHICO PHARMACEUTICALS LIMITED
(The Company was incorporated on 4"' December 1991 as Plethico
Pharmaceuticals Private Limited under the Companies Act, 1956.In 1992, our Company was
converted to a public limited company and received a fresh certificate of incorporation on
27" August 1992. For details of incorporation and change in name, please refer to the
chapter on Our History and Corporate Structure at Page 120).
Registered Office: A.B.Road, Manglia-453 771, Indore (M.P.), India. Tel:
+91-0731-2422881-85;
Fax: +91-0731-2420938;
Corporate Office: Plethico Pharmaceuticals Limited, 1st Floor, Crimpage
Corporation, Plot No. 57, Street No.17, M.I.D.C, Andheri (E) Mumbai-400093.
Tel: +91-022-56988301; Fax: +91-022-56988330. Compliance
Officer: Mr. Pankaj Pabaiya;
E-mail: ipo@plethico.com; Website:
www.plethico.com
BASIS OF ALLOTMENT
PUBLIC ISSUE OF 36,66,667 EQUITY SHARES OF RS. 10 EACH FOR CASH AT A PRICE OF
RS. 300 PER EQUITY SHARE (INCLUDING A SHARE PREMIUM OF RS 290 PER EQUITY SHARE)
AGGREGATING RS. 1100 MILLION, (the "ISSUE"), BY PLETHICO PHARMACEUTICALS LIMITED
("PLETHICO", the "COMPANY" or "tile ISSUER"). THE ISSUE WILL
CONSTITUTE 10.76 % OF THE FULLY DILUTED POST-ISSUE PAID-UP CAPITAL OF OUR COMPANY
ISSUE PRICE Rs. 300 PER EQUITY SHARE OF FACE VALUE Rs.10. THE FACE VALUE OF THE
SHARES IS Rs. 10 AND THE ISSUE PRICE IS 30 TIMES OF THE FACE VALUE.
In terns of Rule 19(2)(b) of the SCRR, this being an offer for less than 25% of the post
Issue Capital, the Issue was made through the 100% Book Building Process wherein atleast
60% of the Issue to the public was allocated on a proportionate basis to Qualified
Institutional Buyers, out of which 5% of the QIB Portion was made available for allocation
on a proportionate basis to Mutual Funds only, and the remaining QIB Portion was available
for allocation on a proportionate basis to all Qualified Institutional Buyers, including
Mutual Funds. Further, not less than 10% of the Issue to the public was available for
allocation on a proportionate basis to Non-Institutional Bidders and not less than 30% of
the Issue to the public was available for allocation on a proportionate basis to Retail
Individual Bidders, subject to valid Bids being received at or above the Issue Price.
The Issue received 1,46,586 applications for 9,28,18,560
Equity Shares resulting in 25.3142 times subscription. The details of the
applications received in the Issue from Retail Bidders / Investors, Non-Institutional
Bidders / Investors and Qualified Institutional Buyers' categories (before technical
rejections) are as under:
Category |
No. of Applications |
No. of Equity Shares Applied For |
Subscription (*) |
Retail Investors |
1,46,179 |
2,13,69,920 |
19.4272 |
Non-Institutional Investors |
350 |
1,57,65,420 |
42.9966 |
Qualified Institutional Buyers |
57 |
5,56,83,220 |
25.3106 |
Total |
1,46,586 |
9,28,18,560 |
25.3142 |
(*): Note: Number of times of the respective category.
Final Demand
A sample of the final demand at different bid prices is as under:
Bid Price
(Rs./ Share) |
No. of Equity Shares |
% to Total Bids |
Cumulative Total Bids |
Cumulative % to Total Bids |
280 |
2424820 |
2.4507 |
98943760 |
100.0000 |
281 |
60 |
0.0001 |
96518940 |
97.5493 |
282 |
9880 |
0.0100 |
96518880 |
97.5492 |
283 |
140 |
0.0001 |
96509000 |
97.5392 |
284 |
420 |
0.0004 |
96508860 |
97.5391 |
285 |
47660 |
0.0482 |
96508440 |
97.5387 |
287 |
680 |
0.0007 |
96460780 |
97.4905 |
288 |
180 |
0.0002 |
96460100 |
97.4898 |
290 |
2425260 |
2.4512 |
96459920 |
97.4896 |
291 |
3440 |
0.0035 |
94034660 |
95.0385 |
292 |
400 |
0.0004 |
94031220 |
95.0350 |
294 |
35380 |
0.0358 |
94030820 |
95.0346 |
295 |
136180 |
0.1376 |
93995440 |
94.9989 |
297 |
200 |
0.0002 |
93859260 |
94.8612 |
298 |
160 |
0.0002 |
93859060 |
94.8610 |
299 |
260 |
0.0003 |
93656900 |
94.8609 |
300 |
73991160 |
74.7810 |
93858640 |
94.8606 |
Cut-off |
19867480 |
20.0796 |
19867480 |
20.0796 |
|
98943760 |
100.0000 |
|
|
The Basis of Allotment was finalized in consultation with Bombay Stock Exchange Limited
('BSE') on Friday, April 28, 2005.
A. Allotment to Retail Investors
The Basis of Allotment to the Retail Investors, who have bid at cut-off or at the Issue
Price of Rs. 300/- per Equity Share, was finalized in consultation with BSE. The category
was over subscribed 19.01795 times. The total number of Equity Shares
allotted in this category is 11,00,000. The category-wise details of the
Basis of Allotment are as under: t'
Category |
No. of
Applications |
% to total |
Total No.of Equity
Shares Applied |
% to total |
No. of Equity
Shares Allotted |
Ratio |
Total No. of Equity
Shares Allotted |
20 |
15864 |
11.04 |
317280 |
1.52 |
20 |
01:19 |
16700 |
40 |
13761 |
9.58 |
550440 |
2.63 |
20 |
02:19 |
28980 |
60 |
10037 |
6.99 |
602220 |
2.88 |
20 |
03:19 |
31700 |
80 |
6871 |
4.78 |
549680 |
2.63 |
20 |
04:19 |
28940 |
100 |
12643 |
8.8 |
1264300 |
6.04 |
20 |
05:19 |
66540 |
120 |
4063 |
2.83 |
487560 |
2.33 |
20 |
06:19 |
25660 |
140 |
3786 |
2.64 |
530040 |
2.53 |
20 |
07:19 |
27900 |
160 |
46441 |
32.33 |
7430560 |
35.52 |
20 |
08:19 |
391060 |
180 |
1127 |
0.78 |
202860 |
0.97 |
20 |
09:19 |
10680 |
200 |
1630 |
1.13 |
326000 |
1.56 |
20 |
10:19 |
17160 |
220 |
311 |
0.22 |
68420 |
0.33 |
20 |
11:19 |
3600 |
240 |
552 |
0.38 |
132480 |
0.63 |
20 |
12:19 |
6980 |
260 |
238 |
0.17 |
61880 |
0.3 |
20 |
13:19 |
3260 |
280 |
268 |
0.19 |
75040 |
0.36 |
20 |
14:19 |
3940 |
300 |
1071 |
0.75 |
321300 |
1.54 |
20 |
15:19 |
16920 |
320 |
24999 |
17.4 |
7999680 |
38.24 |
20 |
21:25 |
419980 |
B. Allotment to Non-Institutional Investors
The Basis of Allotment to the Non-institutional Investors, who have bid at the issue Price
of Rs. 300/- per Equity Share, was finalized in consultation with BSE. The category was
subscribed 42.95665 times. The total number of Equity Shares allotted in
this category is 3,66,667. The category-wise details of the Basis of
Allotment are as under:
Category |
No. of
Applications |
% to total |
Total No.of Equity
Shares Applied |
% to total |
No. of Equity
Shares Allotted |
Ratio |
Total No. of Equity
Shares Allotted |
33340 |
7 |
2.05 |
233380 |
1.48 |
776 |
FIRM |
5432 |
66660 |
4 |
1.17 |
266640 |
1.69 |
1552 |
FIRM |
6208 |
100000 |
4 |
1.17 |
400000 |
2.54 |
2328 |
FIRM |
9312 |
166660 |
1 |
0.29 |
166660 |
1.06 |
3880 |
FIRM |
3880 |
174600 |
1 |
0.29 |
174600 |
1.11 |
4064 |
FIRM |
4064 |
214000 |
1 |
0.29 |
214000 |
1.36 |
4982 |
FIRM |
4982 |
250000 |
1 |
0.29 |
250000 |
1.59 |
5820 |
FIRM |
5820 |
333300 |
1 |
0.29 |
333300 |
2.12 |
7759 |
FIRM |
7759 |
633320 |
1 |
0.29 |
633320 |
4.02 |
14743 |
FIRM |
14743 |
666660 |
1 |
0.29 |
666660 |
4.23 |
15519 |
FIRM |
15519 |
2500000 |
1 |
0.29 |
2500000 |
15.87 |
58191 |
FIRM |
58191 |
3400000 |
1 |
0.29 |
3400000 |
21.59 |
79134 |
FIRM |
79134 |
3666660 |
1 |
0.29 |
3666860 |
23.28 |
85340 |
FIRM |
85340 |
C. Allotment to QIBs
The total number of Equity Shares allotted 01 Bs is22,00,000 Equity Shares as follows:
Category |
FIs/Banks |
MFs |
FIIs |
Insurance Companies |
Venture Capitals |
Total |
No. of Shares |
1,91,174 |
4,93,515 |
14,32,573 |
82,738 |
- |
22,00,000 |
Pursuant to Clause 6.8.3.2 (g) of the SEBI (Disclosure and Investor Protection
Guidelines), 2000 and item no. 19 of the Notes to the Capital Structure (page no. 25) of
the Prospectus dated April 19, 2006 the Company has rounded-off fractional Equity Shares
to the nearest multiple of one (1) Equity Share.
The Committee of Directors for Initial Public Offering ('IPO') of the Company at it's
Meeting held at lndore on April 29, 2006 has approved the basis of allocation of shares
and allotted the shares to various successful applicants.
The Refund Orders will be dispatched to the address of the investors as registered with
the depositories in case the same is not received within ten (10) days, investors may
contact at the address given below. The Refund Orders have been over-printed with the Bank
Mandate details as registered, if any, with the depositories. The Equity Shares allotted
to successful applicants are being credited to their respective beneficiary accounts
subject to validation of the account details with the depositories concerned. The Company
is taking steps to get the Equity Shares admitted for trading on Bombay Stock Exchange
Limited and National Stock Exchange of India Limited within seven (7) working days from
the date of approval of the Basis of Allotment.
INVESTORS MAY PLEASE NOTE
These details of allotment made, would be hosted on the website of the Registrar to the
Issue, Intime Spectrum Registry Limited at www.intimespectrum.com
All future correspondence in this regard may kindly be addressed to the Registrar to the
Issue, Intime Spectrum Registry limited, quoting full name of the First/ Sole Applicant,
Serial Number of the Bid-cum-Application Form, Number of Equity Shares bid for, Name of
the Member of the Syndicate, Place where the bid was submitted and payment details at the
address given below:
Intime Spectrum Registry Limited
Unit: Plethico Pharmaceuticals Limited
C-13, Pannalal Silk Mills Compound, LBS Marg, Bhandup (West), Mumbai -400 078
TelephoneNo.:+91-22-25960320-28;FaxNo.:+91-22-25960329;Email:plethicoipo@intimespectrum.com
Place: Indore
Date: May 02, 2006 |
For Plethico Pharmaceuticals Limited
Sd/-
Shashikant Patel
Chairman & Managing Director |
THE LEVELOF SUBSCRIPTION SHOULD NOT BE TAKEN TO BE INDICATIVE OF EITHER THE
MARKET PRICE OFTHE EQUITY SHARE ON LISTING OR THE BUSINESS PROSPECTS OF PLETHICO
PHARMACEUTICALS LIMITED. |